X = Y(A - B) ------- AWarrant Agreement • March 31st, 2006 • PTC Therapeutics, Inc. • Delaware
Exhibit 10.12 Table of Contents TABLE OF CONTENTS OF LEASE BETWEEN 46.24 ASSOCIATES L.P., AS LANDLORD, AND PTC THERAPEUTICS, INC., AS TENANT, FOR PREMISES LOCATED IN 100 CORPORATE COURT, MIDDLESEX BUSINESS CENTER, SOUTH PLAINFIELD, NEW JERSEYLease Agreement • March 31st, 2006 • PTC Therapeutics, Inc. • New Jersey
X = Y (A - B) --------- AWarrant Agreement • March 31st, 2006 • PTC Therapeutics, Inc. • Delaware
Exhibit 4.4 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY APPLICABLE STATE SECURITIES LAW, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE...Warrant Agreement • March 31st, 2006 • PTC Therapeutics, Inc. • New Jersey
WARRANTWarrant Agreement • March 31st, 2006 • PTC Therapeutics, Inc. • New York
Exhibit 10.5 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT dated as of March 17, 2006 by and between PTC THERAPEUTICS, INC.Collaboration and License Agreement • March 31st, 2006 • PTC Therapeutics, Inc. • New York
MASTER SECURITY AGREEMENT NO. 4081064 Dated as of JULY 30, 2004 ("AGREEMENT")Master Security Agreement • March 31st, 2006 • PTC Therapeutics, Inc. • Virginia
EXHIBIT 4.2 FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this "Agreement") made as of September 21, 2005 (the "Effective Date") by and among (i) PTC Therapeutics, Inc., a Delaware...Investor Rights Agreement • March 31st, 2006 • PTC Therapeutics, Inc. • Delaware
EXHIBIT 10.14 PROMISSORY NOTE TO MASTER SECURITY AGREEMENT NO. _________Promissory Note • March 31st, 2006 • PTC Therapeutics, Inc. • Virginia
FOR VALUE RECEIVED, PTC Therapeutics, Inc., a Delaware corporation, located at the address stated below ("MAKER") promises, jointly and severally if more than one, to pay to the order of OXFORD FINANCE CORPORATION or any subsequent holder hereof (each, a "PAYEE") at its office located at 133 N. FAIRFAX STREET, ALEXANDRIA, VA 22314 or at such other place as Payee or the holder hereof may designate, the principal sum of ____________________ DOLLARS ($____________________), with interest on the unpaid principal balance, from the date hereof through and including the dates of payment, at a fixed interest rate of ______ and _____ hundredths percent (____%) per annum, in ________ consecutive monthly installments of principal and interest as follows:
RECITALSResearch Collaboration and Exclusive Option Agreement • March 31st, 2006 • PTC Therapeutics, Inc. • New York
